Cytarabine Dose for Acute Myeloid Leukemia

B. Lowenberg, T. Pabst, E. Vellenga, W van Putten, H.C. Schouten, C. Graux, A Ferrant, P. Sonneveld, B.J. Biemond, A. Gratwohl, G.E. de Greef, L.F. Verdonck, M.R. Schaafsma, M. Gregor, M Theobald, U. Schanz, J. Maertens, G.J. Ossenkoppele

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1027-1036
JournalNew England Journal of Medicine
Volume364
Issue number11
DOIs
Publication statusPublished - 2011

Cite this

Lowenberg, B., Pabst, T., Vellenga, E., van Putten, W., Schouten, H. C., Graux, C., ... Ossenkoppele, G. J. (2011). Cytarabine Dose for Acute Myeloid Leukemia. New England Journal of Medicine, 364(11), 1027-1036. https://doi.org/10.1056/NEJMoa1010222